Posterior chamber phakic intraocular lens adjustment-causes and complications: a retrospective cohort study.

IF 1.9 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-05-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.05.14
Ghufran Alarfaj, Halah Bin Helayel, Majed AlSubaie, Jumana Hariri, Fatima Alzaher, Omar Khan, Mohanna Al-Jindan, Ahmed AlHabash, Naif M Sulaimani
{"title":"Posterior chamber phakic intraocular lens adjustment-causes and complications: a retrospective cohort study.","authors":"Ghufran Alarfaj, Halah Bin Helayel, Majed AlSubaie, Jumana Hariri, Fatima Alzaher, Omar Khan, Mohanna Al-Jindan, Ahmed AlHabash, Naif M Sulaimani","doi":"10.18240/ijo.2025.05.14","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the visual outcomes of implantable collamer lenses (ICLs) and identify the possible risk factors for ICL axis misalignment, and consequently, repositioning, explanting, or exchanging at a specialized eye hospital in Saudi Arabia.</p><p><strong>Methods: </strong>The medical records of 813 eyes with different refractive errors corrected with ICL implantation were identified and included in this single-arm retrospective cohort study. The following data were collected: demographic characteristics, primary diagnosis, preoperative refraction, anterior chamber depth (ACD), white-to-white (WTW) measurement, endothelial cell density (ECD), and axial length. Patients' satisfaction and complaints, and their postoperative refraction, vault depth, and axis alignment with the preoperative target, were reviewed during the postoperative period. Collectively, these data were correlated with symptomatic axis rotation and the need for repositioning, explantation, or exchange due to high or low ICL vaults.</p><p><strong>Results: </strong>Of 813 eyes, 27 (3.32%), 13 (1.59%), and 11 (1.35%) required ICL repositioning, ICL explantation only without exchange, and ICL explantation with the placement of a new ICL, respectively. The mean follow-up period was 37.5mo. The main cause of explanation or exchange was incorrect WTW measurement in seven (29.17%) eyes, followed by high vault in four (16.56%) eyes. ICL repositioning was required in 27 (3.32%) eyes with considerable rotation. Only 2 (0.24%) eyes developed cataracts that required ICL removal, and retinal complications were reported in 7 (0.86%) eyes. Long-term glaucoma and corneal decompensation were not observed in this cohort.</p><p><strong>Conclusion: </strong>With a high safety profile and reversibility, ICL implantation is a good alternative to corneal-based refractive surgery in eyes unsuitable for laser vision correction. The rate of secondary procedures in our study was 6.26%. Old age is a risk factor for secondary surgical interventions in the repositioning group, whereas abnormal vault and toric ICL rotation in the explantation group necessitated subsequent surgical procedures. Overall, ICL implantation demonstrates a good efficacy index and safety profile in patients with diverse refractive errors.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 5","pages":"883-888"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043295/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.05.14","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To evaluate the visual outcomes of implantable collamer lenses (ICLs) and identify the possible risk factors for ICL axis misalignment, and consequently, repositioning, explanting, or exchanging at a specialized eye hospital in Saudi Arabia.

Methods: The medical records of 813 eyes with different refractive errors corrected with ICL implantation were identified and included in this single-arm retrospective cohort study. The following data were collected: demographic characteristics, primary diagnosis, preoperative refraction, anterior chamber depth (ACD), white-to-white (WTW) measurement, endothelial cell density (ECD), and axial length. Patients' satisfaction and complaints, and their postoperative refraction, vault depth, and axis alignment with the preoperative target, were reviewed during the postoperative period. Collectively, these data were correlated with symptomatic axis rotation and the need for repositioning, explantation, or exchange due to high or low ICL vaults.

Results: Of 813 eyes, 27 (3.32%), 13 (1.59%), and 11 (1.35%) required ICL repositioning, ICL explantation only without exchange, and ICL explantation with the placement of a new ICL, respectively. The mean follow-up period was 37.5mo. The main cause of explanation or exchange was incorrect WTW measurement in seven (29.17%) eyes, followed by high vault in four (16.56%) eyes. ICL repositioning was required in 27 (3.32%) eyes with considerable rotation. Only 2 (0.24%) eyes developed cataracts that required ICL removal, and retinal complications were reported in 7 (0.86%) eyes. Long-term glaucoma and corneal decompensation were not observed in this cohort.

Conclusion: With a high safety profile and reversibility, ICL implantation is a good alternative to corneal-based refractive surgery in eyes unsuitable for laser vision correction. The rate of secondary procedures in our study was 6.26%. Old age is a risk factor for secondary surgical interventions in the repositioning group, whereas abnormal vault and toric ICL rotation in the explantation group necessitated subsequent surgical procedures. Overall, ICL implantation demonstrates a good efficacy index and safety profile in patients with diverse refractive errors.

后房型晶状体调整的原因和并发症:一项回顾性队列研究。
目的:评价沙特阿拉伯一家眼科专科医院植入式晶体(ICL)的视力结果,并确定可能导致ICL轴错位的危险因素,从而导致重新定位、移植或更换。方法:对813只不同屈光不正的人工晶体植入术患者的病历进行单臂回顾性队列研究。收集以下数据:人口统计学特征、初步诊断、术前屈光、前房深度(ACD)、白对白(WTW)测量、内皮细胞密度(ECD)和轴向长度。术后回顾患者的满意度和抱怨,以及术后屈光、穹窿深度和与术前目标的轴线对齐情况。总的来说,这些数据与有症状的轴旋转以及由于高或低ICL穹窿而需要重新定位、外植体或交换相关。结果:813只眼中,分别有27只(3.32%)、13只(1.59%)和11只(1.35%)需要ICL重新定位、ICL仅移植而不移植和ICL移植并放置新ICL。平均随访37.5个月。解释或交流的主要原因为7只(29.17%)眼WTW测量不正确,其次为4只(16.56%)眼跳高。旋转较大的27眼(3.32%)需要重新定位ICL。仅有2只眼(0.24%)发生白内障,需要摘除ICL, 7只眼(0.86%)出现视网膜并发症。在这个队列中没有观察到长期青光眼和角膜失代偿。结论:ICL植入术具有较高的安全性和可逆性,是不适合激光视力矫正的患者角膜屈光手术的良好选择。在我们的研究中,二次手术的比率为6.26%。在复位组中,年龄是二次手术干预的危险因素,而在外植体组中,异常拱顶和环面ICL旋转需要后续手术治疗。总的来说,ICL植入术在各种屈光不正患者中表现出良好的疗效指数和安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信